Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Calcium Chlortetracycline
2. Chlorotetracycline Calcium Salt
3. Calcium-chlortetracycline Complex
4. Chlortetracycline Calcium Complex
5. Nr4b2sx17s
6. Chlortetracycline Calcium Complex [green Book]
7. 57122-99-3
8. 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide Calcium Salt
9. Chlortetracycline Calcium [who-dd]
10. Unii-nr4b2sx17s
11. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Calcium Salt (2:1), (4s-(4alpha,4aalpha,5aalpha,6beta,12aalpha))-
12. Q27285004
13. 2-naphthacenecarboxamide, 7-chloro-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, Calcium Salt (2:1), (4s-(4.alpha.,4a.alpha.,5a.alpha.,6.beta.,12a.alpha.))-
| Molecular Weight | 995.8 g/mol |
|---|---|
| Molecular Formula | C44H44CaCl2N4O16 |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 18 |
| Rotatable Bond Count | 4 |
| Exact Mass | 994.1755276 g/mol |
| Monoisotopic Mass | 994.1755276 g/mol |
| Topological Polar Surface Area | 369 Ų |
| Heavy Atom Count | 67 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 10 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
ABOUT THIS PAGE
A UNII-NR4B2SX17S manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of UNII-NR4B2SX17S, including repackagers and relabelers. The FDA regulates UNII-NR4B2SX17S manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. UNII-NR4B2SX17S API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A UNII-NR4B2SX17S supplier is an individual or a company that provides UNII-NR4B2SX17S active pharmaceutical ingredient (API) or UNII-NR4B2SX17S finished formulations upon request. The UNII-NR4B2SX17S suppliers may include UNII-NR4B2SX17S API manufacturers, exporters, distributors and traders.
UNII-NR4B2SX17S Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of UNII-NR4B2SX17S GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right UNII-NR4B2SX17S GMP manufacturer or UNII-NR4B2SX17S GMP API supplier for your needs.
A UNII-NR4B2SX17S CoA (Certificate of Analysis) is a formal document that attests to UNII-NR4B2SX17S's compliance with UNII-NR4B2SX17S specifications and serves as a tool for batch-level quality control.
UNII-NR4B2SX17S CoA mostly includes findings from lab analyses of a specific batch. For each UNII-NR4B2SX17S CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
UNII-NR4B2SX17S may be tested according to a variety of international standards, such as European Pharmacopoeia (UNII-NR4B2SX17S EP), UNII-NR4B2SX17S JP (Japanese Pharmacopeia) and the US Pharmacopoeia (UNII-NR4B2SX17S USP).
LOOKING FOR A SUPPLIER?
